Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prion diseases in man.

F Jacob1, F Ries, M Dicato

  • 1Hematology-Oncology Department, Centre Hospitalier de Luxembourg.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A regional strategy to decrease the time to thrombectomy in patients with low probability of treatment by thrombolysis.

Revue neurologique·2021
Same author

Esophageal stent migration leading to distal small bowel perforation.

Acta gastro-enterologica Belgica·2020
Same author

Fusion Imaging Reduces Radiation and Contrast Medium Exposure During Endovascular Revascularization of Iliac Steno-Occlusive Disease.

Cardiovascular and interventional radiology·2019
Same author

Genotypic and phenotypic diversity of Lactobacillus rossiae isolated from beer.

Journal of applied microbiology·2019
Same author

Endovascular stent-based revascularization of malignant superior vena cava syndrome with concomitant implantation of a port device using a dual venous approach.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2017
Same author

Letrozole may be a valuable maintenance treatment in high-grade serous ovarian cancer patients.

Gynecologic oncology·2017
Same journal

Corrigendum to "Targeting PD-L1 and disrupting Siglec-9 cooperatively potentiate macrophage phagocytosis of breast cancer via a trispecific macrophage engager (TriME)" [Biomed. Pharmacother. 200 (2026), 119609].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Targeted attenuation of liver fibrosis using microbubble-enhanced protease-activated receptor 1 chimeric antigen receptor T cells.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Euphol targets key oncogenic processes and promotes chemoprevention in organoid and In Vivo models of colorectal cancers.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

CAR-T cell therapy and oncolytic viruses: A synergic approach for advanced GI cancers.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Corrigendum to "Antidiabetic sitagliptin influences tissue regeneration by affecting progenitor cells" [Biomed. Pharmacother. 189 (2025) 118279].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same journal

Corrigendum: "Zebrafish as a model to study inflammation: A tool for drug discovery" [Biomed. Pharmacother. 144 (2021) 112310].

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
See all related articles

Human spongiform encephalopathies (HSE) are rare neurodegenerative diseases. While often viewed as infectious, genetic links are emerging, suggesting a dual nature for these prion-related disorders.

Area of Science:

  • Neurodegenerative diseases
  • Prion biology
  • Genetics of neurological disorders

Background:

  • Human spongiform encephalopathies (HSE) are rare neurodegenerative conditions with unclear causes.
  • Evidence suggests HSE may be caused by unconventional infectious agents, known as prions.
  • Recent findings indicate genetic factors may also predispose individuals to HSE.

Purpose of the Study:

  • To explore the etiology of human spongiform encephalopathies.
  • To investigate the potential roles of both infectious agents and genetic factors in HSE.
  • To reconcile the prion-type disorder hypothesis with genetic linkage findings.

Main Methods:

  • Review of existing observations on HSE.
  • Analysis of recent discoveries concerning predisposing allelic variants.

Related Experiment Videos

  • Comparative assessment of infectious versus genetic models for HSE.

    • Main Results:

    • Observations support the infectious prion-type agent hypothesis for HSE.
    • Discovery of predisposing genetic variants challenges a purely infectious model.
    • HSE may represent a spectrum influenced by both infectious and genetic factors.

    Conclusions:

    • The etiology of HSE is complex, potentially involving both infectious and genetic components.
    • HSE might be viewed as a genetically linked disease in some cases.
    • Further research is needed to fully understand the interplay of factors in HSE pathogenesis.